InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,300.70
(
1.03%
)
US TECH 100
18,097.60
(
1.46%
)
Dow Jones
39,835.81
(
0.70%
)
Brent Oil
82.64
(
0.10%
)
Bitcoin
65,471.57
(
6.38%
)
Post# of 251825
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 179227

Friday, 06/13/2014 5:58:16 AM

Friday, June 13, 2014 5:58:16 AM

Post# of 251825
Recall Teva's ANDA for generic Baraclude got an FDA tentative approval in Oct. 2013 after earlier that year the Delaware District Court ruled that Baraclude's CoM patent was invalid. Seems that since the ruling in the Protonix case against Teva (and Sun), they are very careful about "at risk" launch.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up